ATE229809T1 - Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten - Google Patents

Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten

Info

Publication number: ATE229809T1
Authority: AT; Austria
Prior art keywords: magnesium; pharmaceutically acceptable; treatment; prophylaxis; cancer
Prior art date: 1994-05-25

Application number

AT95920208T

Other languages

English (en)

Inventor

Giampiero Valletta

Original Assignee

Giampiero Valletta

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-25

Filing date

1995-05-24

Publication date

2003-01-15

1995-05-24 Application filed by Giampiero Valletta filed Critical Giampiero Valletta

2003-01-15 Application granted granted Critical

2003-01-15 Publication of ATE229809T1 publication Critical patent/ATE229809T1/de

Links

FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title abstract 3
229910052749 magnesium Inorganic materials 0.000 title abstract 3
239000011777 magnesium Substances 0.000 title abstract 3
238000011282 treatment Methods 0.000 title abstract 2
208000023275 Autoimmune disease Diseases 0.000 title 1
206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
238000011321 prophylaxis Methods 0.000 title 1
159000000003 magnesium salts Chemical class 0.000 abstract 4
XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
229940091250 magnesium supplement Drugs 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
230000001613 neoplastic effect Effects 0.000 abstract 2
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
208000009956 adenocarcinoma Diseases 0.000 abstract 1
230000037396 body weight Effects 0.000 abstract 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 abstract 1
229940069446 magnesium acetate Drugs 0.000 abstract 1
235000011285 magnesium acetate Nutrition 0.000 abstract 1
239000011654 magnesium acetate Substances 0.000 abstract 1
229960001983 magnesium aspartate Drugs 0.000 abstract 1
OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 abstract 1
229960004658 magnesium lactate Drugs 0.000 abstract 1
235000015229 magnesium lactate Nutrition 0.000 abstract 1
239000000626 magnesium lactate Substances 0.000 abstract 1
RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 abstract 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
239000011726 vitamin B6 Substances 0.000 abstract 1
235000019158 vitamin B6 Nutrition 0.000 abstract 1
229940011671 vitamin b6 Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT95920208T 1994-05-25 1995-05-24 Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten ATE229809T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ITRM940328A IT1272994B (it)	1994-05-25	1994-05-25	Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-
PCT/IT1995/000089 WO1995031991A2 (en)	1994-05-25	1995-05-24	Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases

Publications (1)

Publication Number	Publication Date
ATE229809T1 true ATE229809T1 (de)	2003-01-15

Family

ID=11402556

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95920208T ATE229809T1 (de)	1994-05-25	1995-05-24	Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten

Country Status (15)

Country	Link
US (2)	US6248368B1 (de)
EP (1)	EP0760668B1 (de)
JP (1)	JP3721196B2 (de)
KR (1)	KR100363031B1 (de)
CN (1)	CN1111414C (de)
AT (1)	ATE229809T1 (de)
AU (1)	AU691617B2 (de)
CA (1)	CA2190847C (de)
DE (1)	DE69529213T2 (de)
DK (1)	DK0760668T3 (de)
ES (1)	ES2188663T3 (de)
IT (1)	IT1272994B (de)
PT (1)	PT760668E (de)
RU (2)	RU2163487C2 (de)
WO (1)	WO1995031991A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1076197C (zh) *	1997-08-20	2001-12-19	许跃远	一种治疗乳腺疾病的药
US6639265B2 (en)	2000-01-26	2003-10-28	Semiconductor Energy Laboratory Co., Ltd.	Semiconductor device and method of manufacturing the semiconductor device
US6506412B2 (en) *	2000-11-29	2003-01-14	Sciencebased Health	Treatment of dry eye syndrome
US7097860B2 (en) *	2001-08-03	2006-08-29	Aaron Moshenyat	Method and composition for treatment of inflammatory and inflammation-related disorders
US6537590B1 (en) *	2002-02-19	2003-03-25	Troy J. Lee	Solution and the method of making the same for the treatment of osteoarthritis
RU2232560C2 (ru) *	2002-04-05	2004-07-20	Саратовский научно-исследовательский институт травматологии и ортопедии	Способ лечения аутоиммунного артрита у животных
US7247328B2 (en) *	2002-05-31	2007-07-24	Zinpro Corporation	Chromium (III) alpha amino acid complexes
US7129375B2 (en)	2002-10-16	2006-10-31	Zinpro Corporation	Metal complexes of α amino dicarboxylic acids
RU2237466C1 (ru) *	2003-02-06	2004-10-10	Покатилов Игорь Олегович	Способ коррекции избыточного жироотложения проблемных зон
RU2263316C2 (ru) *	2003-04-04	2005-10-27	Военно-медицинский институт Федеральной пограничной службы Российской Федерации при Нижегородской государственной медицинской академии (ВМИ ФПС РФ при НГМА)	Способ диагностики дефицита магния при внутренней патологии
WO2005039662A2 (en) *	2003-10-10	2005-05-06	Kw2 Implantattechnologie Gmbh	Cartilage regeneration by generation of chondrons under high concentrations of magnesium
EP1522322A1 (de) *	2003-10-10	2005-04-13	Witte, Frank, Dr.	Knorpelregeneration
WO2005077405A1 (en) *	2004-02-06	2005-08-25	Cancer Treatment International	Compositions and methods for the treatment of cancer by systemic elevation of lactate and consequent depletion of arginine
US20060141054A1 (en) *	2004-10-25	2006-06-29	Thomas Piccariello	Metal coordinated compositions
US7799937B2 (en)	2004-10-25	2010-09-21	Synthonics, Inc.	Metal coordinated compositions
US8779175B2 (en)	2004-10-25	2014-07-15	Synthonics, Inc.	Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
FI119101B (fi) *	2006-01-24	2008-07-31	Medgenerics Oy	Magnesiumsuoloja sisältävä hoitoaine kasvainten tai vastaavien hoitoon ja magnesiumsulfaatin käyttö
RU2336076C2 (ru) *	2006-06-22	2008-10-20	Закрытое акционерное общество "Биоамид"	Пероральное лекарственное средство для восполнения дефицита магния в организме
US8945505B2 (en) *	2007-02-02	2015-02-03	Panaphix, Inc.	Use of arsenic compounds for treatment of pain and inflammation
US8815232B2 (en)	2008-08-26	2014-08-26	Kyon Biotech Ag	Compositions and methods for treating cancer
KR102075024B1 (ko) *	2018-01-25	2020-02-07	염창환	마그네슘 화합물을 유효성분으로 포함하는 항암보조제
CN108936149A (zh) *	2018-05-21	2018-12-07	胡宪蕴	一种含纳米硒的多元素复合补充剂及应用
CN109674819B (zh) *	2018-12-21	2023-05-05	博雅干细胞科技有限公司	胎盘间充质干细胞制剂及其治疗硬化病的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5244637A (en) *	1975-10-04	1977-04-07	Fuji Photo Optical Co Ltd	Exposure information display device
IT1124697B (it) *	1979-10-26	1986-05-14	Simes	Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US4975423A (en) *	1984-06-27	1990-12-04	Colgate-Palmolive Company	Inhibition of tumor development
SU1537260A1 (ru) *	1987-08-03	1990-01-23	1-Я Городская Клиническая Больница Г.Новосибирска	Способ предупреждени развити отека набухани головного мозга при черепно-мозговой травме
US5035888A (en) *	1988-11-09	1991-07-30	Tadataka Hara	Therapeutically useful mineral composition
US5977073A (en) *	1991-06-06	1999-11-02	Life Sciences' Technologies, Inc.	Nutrient composition for treatment of immune disorders
US5626883A (en) *	1994-04-15	1997-05-06	Metagenics, Inc.	Ascorbic acid compositions providing enhanced human immune system activity

1994
- 1994-05-25 IT ITRM940328A patent/IT1272994B/it active IP Right Grant
1995
- 1995-05-24 ES ES95920208T patent/ES2188663T3/es not_active Expired - Lifetime
- 1995-05-24 WO PCT/IT1995/000089 patent/WO1995031991A2/en not_active Ceased
- 1995-05-24 US US08/737,743 patent/US6248368B1/en not_active Expired - Fee Related
- 1995-05-24 AT AT95920208T patent/ATE229809T1/de not_active IP Right Cessation
- 1995-05-24 KR KR1019960706651A patent/KR100363031B1/ko not_active Expired - Fee Related
- 1995-05-24 EP EP95920208A patent/EP0760668B1/de not_active Expired - Lifetime
- 1995-05-24 DK DK95920208T patent/DK0760668T3/da active
- 1995-05-24 CA CA002190847A patent/CA2190847C/en not_active Expired - Fee Related
- 1995-05-24 PT PT95920208T patent/PT760668E/pt unknown
- 1995-05-24 AU AU25742/95A patent/AU691617B2/en not_active Ceased
- 1995-05-24 DE DE69529213T patent/DE69529213T2/de not_active Expired - Fee Related
- 1995-05-24 CN CN95193277A patent/CN1111414C/zh not_active Expired - Fee Related
- 1995-05-24 RU RU96124484/14A patent/RU2163487C2/ru not_active IP Right Cessation
- 1995-05-24 JP JP53018295A patent/JP3721196B2/ja not_active Expired - Fee Related
2000
- 2000-12-21 RU RU2000132310/14A patent/RU2000132310A/ru not_active Application Discontinuation
2001
- 2001-05-11 US US09/852,619 patent/US6589564B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO1995031991A3 (en)	1996-02-15
EP0760668B1 (de)	2002-12-18
JP3721196B2 (ja)	2005-11-30
JPH10500678A (ja)	1998-01-20
DE69529213D1 (de)	2003-01-30
IT1272994B (it)	1997-07-01
US20010041191A1 (en)	2001-11-15
CA2190847A1 (en)	1995-11-30
US6589564B2 (en)	2003-07-08
CA2190847C (en)	2004-03-16
DE69529213T2 (de)	2003-11-13
US6248368B1 (en)	2001-06-19
KR970703155A (ko)	1997-07-03
PT760668E (pt)	2003-04-30
EP0760668A1 (de)	1997-03-12
ITRM940328A0 (it)	1994-05-25
WO1995031991A2 (en)	1995-11-30
RU2163487C2 (ru)	2001-02-27
RU2000132310A (ru)	2003-01-27
AU2574295A (en)	1995-12-18
CN1111414C (zh)	2003-06-18
CN1149255A (zh)	1997-05-07
AU691617B2 (en)	1998-05-21
DK0760668T3 (da)	2003-03-31
ITRM940328A1 (it)	1995-11-25
ES2188663T3 (es)	2003-07-01
KR100363031B1 (ko)	2003-04-10

Legal Events

Date

Code

Title

Description

2003-06-15

UEP

Publication of translation of european patent specification

Ref document number: 0760668

Country of ref document: EP

2006-02-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE229809T1 (de)	2003-01-15	Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
Kallistratos et al.	1980	Inhibition of benzo (a) pyrene carcinogenesis in rats with vitamin C
NZ513960A (en)	2004-02-27	Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
GB0223380D0 (en)	2002-11-13	Combination therapy
HUT60630A (en)	1992-10-28	Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
IL107134A0 (en)	1993-12-28	Pharmaceutical compositions for the treatment of parkinson's disease
WO2004045593A3 (en)	2004-08-12	Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
HUT73433A (en)	1996-07-29	Process for preparing pharmaceutical compositions containing riluzole for treating aids-related neural disorders
CA2464758A1 (en)	2003-05-15	Combination therapy comprising zd6474 and a taxane
BR9500436A (pt)	1995-10-17	Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
HU213677B (en)	1997-12-29	Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
KR970061244A (ko)	1997-09-12	치매 치료용 약학 조성물
EP1458734A4 (de)	2007-12-19	Derivate von isoindigo, indigo und indirubin und deren verwendung bei der behandlung von krebs
JPS58501676A (ja)	1983-10-06	微量物質としてセレニウムをヒトに供給するための混合物、ならびに細胞培養のための培地中に器官を保存する溶液および血液成分を保存する栄養溶液におけるその使用
RU2003132465A (ru)	2005-03-10	Композиция и способы профилактики и лечения рака предстательной железы человека
DE59409394D1 (de)	2000-07-13	Therapeutisches system zur behandlung der psoriasis
WO1987000432A3 (en)	1987-05-21	Use of melatonin or related compounds for the treatment of psoriasis
MX9300204A (es)	1994-07-29	Composicion farmaceutica que contiene azauridina para el tratamiento de la artritis reumatoide.
US3705946A (en)	1972-12-12	Method of treating hyperuricemia
EP0804185B1 (de)	2000-02-02	Arsen-enthaltende arzneimittel zur behandlung des chronischen ermüdungssyndroms
KR920702225A (ko)	1992-09-03	약학 조성물
JPS6470417A (en)	1989-03-15	Method and composition for treating psoriasis
FR2500303B1 (de)	1983-12-30
UA50728C2 (uk)	2002-11-15	Спосіб стимуляції імунної системи за допомогою димеру лізоциму
US3873722A (en)	1975-03-25	Method for treating schizophrenia